APA (7th ed.) Citation

Sanaa Gamrani, Laila Akhouayri, Sara Boukansa, Mehdi Karkouri, & Hinde El Fatemi. (2023). The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status. Hindawi-Wiley.

Chicago Style (17th ed.) Citation

Sanaa Gamrani, Laila Akhouayri, Sara Boukansa, Mehdi Karkouri, and Hinde El Fatemi. The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status. Hindawi-Wiley, 2023.

MLA (9th ed.) Citation

Sanaa Gamrani, et al. The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status. Hindawi-Wiley, 2023.